GDF15 and heart failure: Clinical trials reported that GDF-15 is a reliable biomarker of CVD [13,14,15], and heart failure [16], and it has independent prognostic value in patients with coronary artery bypass grafting (CABG) [17], acute coronary syndromes (ACS) [18,19], and heart failure (HF) [20].